TBX6 and Cowden syndrome 1: Liu et al. defined the specific clinical disease entity (TBX6-Associated CS, TACS) which was associated with a combination of a loss-of-function TBX6 lesion and a T-C-A haplotype in trans, as an underlying genetic etiology [7].